Venous protection of acute leukemia treatment with amsacrine
Ma, X.J.; Xiang, Y.M.; Hong, J.
Zhonghua Hu Li Za Zhi 31(9): 506-507
1996
ISSN/ISBN: 0254-1769 PMID: 9295513 Document Number: 460542
Amsacrine (AMSA) was a high effective medicine of acute leukemia treatment. But it could lead to severe phlebitis with venous drip. 44 patients were treated 71 courses with AMSA. After we used fasting venous drip and diluting high concentration AMSA, occurrence of phlebitis remarkably decreased and patients of phlebitis could be cured with early comprehensive nursing.
Document emailed within 1 workday
Related Documents
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880Griffin, J.D.; Maguire, M.E.; Mayer, R.J. 1985: Amsacrine in refractory acute leukemia Cancer Treatment Reports 69(7-8): 787-789
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Abrams, R.A.; Hanson, G.; Hansen, R.M.; Anderson, T. 1986: Phase Ii study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia Cancer Treatment Reports 70(4): 535
Plunkett, W.; Nowak, B.; Keating, M.J. 1987: Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapy Cancer Treatment Reports 71(5): 479-483
Wan, Y.; Wu, D. 1997: Studies on programmed cell death induced by amsacrine and expression of bcl-2 in leukemia cell lines Zhonghua Zhong Liu Za Zhi 19(5): 346-349
Klimenko, V.I.; Romanova, A.F.; Zverkova, A.S.; Evtukh, V.P. 1988: Results of the treatment of acute leukemia in relation to the sensitivity of leukemia cells to cytostatic drugs Vrachebnoe Delo 6: 86-88
Herzog, C.E.; Holmes, K.A.; Tuschong, L.M.; Ganapathi, R.; Zwelling, L.A. 1998: Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha Cancer Research 58(23): 5298-5300
Rozemuller, H.; Rombouts, W.J.; Touw, I.P.; FitzGerald, D.J.; Kreitman, R.J.; Pastan, I.; Hagenbeek, A.; Martens, A.C. 1996: Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model Leukemia 10(11): 1796-1803
Fujimoto, T. 1985: Acute childhood leukemia: treatment results in children's cancer and leukemia group studies 1972-1981 Gan no rinsho. Japan journal of cancer clinics 31(9 Suppl): 1024-1028
Pavlovsky, S. 1981: Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias Sangre 26(5b): 845-854
Skoczeń, S.; Balwierz, W.; Moryl-Bujakowska, A.; Pawińska, K.; Luszczyńska, A.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Pawelec, K.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Wysocki, M.; Styczyńskii, J.; Swiatkiewicz, V. 2006: Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group Przeglad Lekarski 63(1): 11-14
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Restan, A.; Tangen, J.M.; Bergheim, J. 1987: Acute lymphatic leukemia. Acute psychosis during induction treatment Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 107(3): 253-254
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086